Phase 1 is First in human study, approximately 20 patients. Due to start this month.
If results demonstrate safe administration and tolerance in humans, a larger commercial study will commence for approximately 300 participants. This is phase 2 and should commence 2021. Subject to FDA approval, full commercial testing is not that far away, providing phase 1 goes according to plan. AIMO.
General Chat, page-13
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
